China factories

China factory - Henan Lantian Medical Supplies Co.,Ltd.

Henan Lantian Medical Supplies Co.,Ltd.

  • China,Zhengzhou ,Henan
  • Active Member

Leave a Message

we will call you back quickly!

Submit Requirement
China SARS-CoV-2 Coronavirus Neutralizing Antibody Rapid Test
China SARS-CoV-2 Coronavirus Neutralizing Antibody Rapid Test

  1. China SARS-CoV-2 Coronavirus Neutralizing Antibody Rapid Test
  2. China SARS-CoV-2 Coronavirus Neutralizing Antibody Rapid Test

SARS-CoV-2 Coronavirus Neutralizing Antibody Rapid Test

  1. MOQ: To be negotiated
  2. Price: To be negotiated
  3. Get Latest Price
Supply Ability 10000 Kit/Kit per Day
Delivery Time To be negotiated
Packaging Details Kit
Product name 2019-NCoV Neutralizing Antibody Rapid Test (Immunochromatography)
Composition Detection card, sample buffer
Storage conditions 2℃~30℃
term of validity 12 months
Sample requirements Serum, plasma or whole blood
Brand Name ZOSBIO
Model Number 2019-NCoV Neutralizing Antibody
Certification CE BfArm
Place of Origin Henan

View Detail Information

Contact Now Ask for best deal
Get Latest Price Request a quote
  1. Product Details
  2. Company Details

Product Specification

Supply Ability 10000 Kit/Kit per Day Delivery Time To be negotiated
Packaging Details Kit Product name 2019-NCoV Neutralizing Antibody Rapid Test (Immunochromatography)
Composition Detection card, sample buffer Storage conditions 2℃~30℃
term of validity 12 months Sample requirements Serum, plasma or whole blood
Brand Name ZOSBIO Model Number 2019-NCoV Neutralizing Antibody
Certification CE BfArm Place of Origin Henan
High Light 30C Coronavirus Neutralizing Antibody Rapid Testsars-cov-2 neutralizing antibody test kitSARS-CoV-2 Neutralizing Antibody Rapid Test

2019-NCoV Neutralizing Antibody Rapid Test (Immunochromatography) Storage Conditions And Validity

 

Intended Use


This kit is used for the qualitative detection of novel coronavirus (2019-nCoV) neutralizing antibodies in human serum, plasma and whole blood samples.
Novel coronavirus (2019-NCoV) is a novel coronavirus belonging to the genus β. Can cause viral pneumonia, clinical manifestations with fever, fatigue, dry cough, a few patients with nasal congestion, runny nose, sore throat and diarrhea and other symptoms. In severe cases, dyspnea and/or hypoxemia usually develop after a week, and in severe cases, rapid progression to acute respiratory distress syndrome, septic shock, refractory metabolic acidosis, and haemorrhagic dysfunction.
Novel coronavirus has several structural proteins, including spikes (S), envelopments (E), membranes (M), and nucleocapsids (N). The spikes contain a receptor binding domain (RBD) that recognizes the cell surface receptor angiotensin-converting enzyme 2 (ACE2). We found that RBD of the 2019-nCoV spike protein strongly interacts with the human ACE2 receptor, leading to endocytosis of host cells and viral replication in the lung.
2019-nCoV infection or vaccination triggers an immune response that produces antibodies in the blood. They remain in the body's circulatory system for months to years after infection and bind quickly and firmly to the pathogen, preventing the virus from replicating. These antibodies are called neutralizing antibodies. A neutralizing antibody test can determine whether a person has this ability to prevent infection.

 

Principle of Detection


 

This kit is immunochromatographic. The test card contains quality control line C, test line T and control line R. The sample to be tested (serum/plasma/whole blood) diffuses upward through capillary action at the sampling end. S-RBD containing markers in the binding pad binds to the ACE2 protein immobilized on the NC membrane, and the signal can be detected at the T line position. If there is a neutralizing antibody in the sample, it will bind to the labeled S-RBD antigen when passing through the labeling pad. The neutralizing antibody can prevent the binding of S-RBD to ACE2, resulting in a decrease in the signal value. The T-line signal value is negatively correlated with the neutralizing antibody content, and when the neutralizing antibody concentration is high enough, there is no color on the T-line. The control line R and quality control line C should be colored regardless of whether T line is colored or not. Quality control line C is used for quality control. If there is no color display on line C, the test is invalid and the sample must be re-tested.
 

Main Components


The kit consists of a test card and a sample buffer.
Test card: it is composed of aluminum foil bag, desiccant, test strip and plastic card. The test strip is composed of absorbent paper, nitrocellulose membrane, sample pad, binding pad and rubber plate. Nitrocellulose membrane T line (test line) was coated with ACE2 protein, C line (quality control line) was coated with quality control line antibody, R line (control line) was coated with control antibody, and the binding pad contained marker labeled 2019-nCoV antigen.
Sample buffer: phosphate, sodium azide, etc.

 

Storage Conditions and Validity


Store at 2℃ ~ 30℃ for 12 months.
The validity period of the aluminum foil bag is 1h after unpacking.
Batch No. : See label for details.
Expiration date: see label for details.

 

Sample Requirements


1. Collect serum, plasma or whole blood samples.
2. The sediment and suspended matter in the sample may affect the experimental results, and should be removed by centrifugation.
3. Anticoagulants: the use of heparin, EDTA and sodium citrate anticoagulants had no significant effect.
4. Blood collection should be performed by medical professionals. Serum/plasma testing is recommended as a priority. In emergency or special circumstances, a patient's whole blood sample can also be used for rapid testing.
5. Serum and plasma samples should not be stored at room temperature for more than 8h. They can be stored at 2℃ to 8℃ for 5 days and below -20℃ for 6 months, but repeated freeze-thaw cycles should be avoided. The whole blood sample shall not be frozen and stored at 2℃ ~ 8℃ for no more than 48h.

 

Test Method


Read the instructions carefully before the test. Restore all reagents to room temperature before testing. The test should be conducted at room temperature.
1. Take the test card out of the packaged reagent bag and use it within 1 hour.
2. Add 20μl sample (serum, plasma or whole blood) to the filling well of the test card, then add 2 drops (about 60μl) sample buffer, and start timing.
3. Reaction at room temperature for 10 ~ 15 minutes to read the results. The result was invalid after 20 minutes.

 

Interpretation of Test Results


 

Judgment diagram of test card results:
1. Invalid results: no reaction line appeared on the quality control line (line C), and the test was invalid, so the experiment should be redone.
2. Negative results: red bands appear on the test line (Line T), and the color rendering is higher than or equal to the control line (Line R), quality control line (Line C) and control line (Line R).
3. Positive result: no red band appeared on the test line (Line T) or red band appeared on the test line (Line T), but the color rendering was lower than that of the control line (Line R), and the quality control line (Line C) and the control line (Line R).

Limitation of Test Method


 

1. This kit is for qualitative detection and is only used for in vitro auxiliary diagnosis.
2. Make sure you add the right amount of samples for testing. Too many or too few samples may result in inaccurate results.
3. Hemolysis, lipidemia, jaundice and contaminated samples may affect test results and should be avoided.
4. The test results of this reagent are only for clinical reference and should not be used as the sole basis for clinical diagnosis and treatment. The final diagnosis of the disease should be made after a comprehensive evaluation of all clinical and laboratory results.

Product Performance Indicators


1. Analysis of specificity
1.1 Cross-reaction: The following types of antibodies were evaluated for interference with reagents, and the results showed no cross-reaction.

 

SN Item Cross reaction SN Item Cross reaction
1 Endemic human coronavirus OC43 No 10 Enterovirus No
2 Endemic human coronavirus HKUI No 11 EB virus No
3 Endemic human coronavirus NL63 No 12 Measles virus No
4 Endemic human coronavirus 229E No 13 Human cytomegalovirus No
5 Influenza A virus No 14 Rotavirus No
6 Influenza B virus No 15 Norovirus No
7 Respiratory syncytial virus No 16 Mumps virus No
8 Adenovirus No 17 Varicella-zoster virus No
9 Rhinovirus No 18 Mycoplasma pneumoniae No

 

1.2 Interfering Substances: The potential interference of the following substances in the Novel Coronavirus (2019-nCoV) neutralizing antibody test program was evaluated by adding the following substances to a specified concentration sample. The results showed that all kinds of interfering substances did not interfere with the detection results of this reagent.

 

 

Interfering substances Concentration Interfering substances Concentration
Bilirubin ≤50mg/dL Triglycerides ≤15mmol/mL
Hemoglobin ≤5g/L Cholesterol L ≤500mg/d
Rheumatoid factor ≤500IU/mL Human total IgG ≤14mg/mL
Ribavirin 0.4mg/mL Fluticasone 0.5mg/mL
Oxymetazoline 10mg/mL Dexamethasone 5 mg/mL
Histamine hydrochloride 10mg/mL Triamcinolone acetonide 5mg /mL
Tobramycin 1mg/mL Levofloxacin 0.2 mg/mL
Oseltamivir 1mg/mL Azithromycin 0.1 mg/mL
Zanamivir 1mg/mL Ceftriaxone 0.4 mg/mL
Arbidol 0.5mg/mL Meropenem 0.2 mg/mL

 

2. Clinical study: 120 positive samples and 300 negative samples were selected by using the marketed Novel Coronavirus (2019-nCoV) IgG detection reagent (colloidal gold method) as the contrast reagent, and the results were summarized as follows:

 

 

2019-nCoV IgG Ab detection reagent (colloidal goldmethod)

 

Sum

Positive Negative

Positive 115 5 120
Negtive 5 295 300
Sum 120 300 420
Sensitivity 95.83%, (95%CI: 90.62%~98.21%)
Specificity 98.33%, (95%CI: 96.16%~99.29%)

 

 

Precautions


1. This product is only used for in vitro diagnosis.
2. This product is a disposable product, which can not be recycled and reused after use.
3. Read the operation instructions carefully before operation, and carry out the experiment in strict accordance with the reagent instructions.
4. Avoid conducting the experiment in harsh environment (such as environment containing high concentration of corrosive gas and dust such as 84 disinfectant, sodium hypochlorite, acid and alkali or acetaldehyde). Laboratory disinfection should be carried out after the end of the experiment.
5. All samples and used reagents should be regarded as potentially infectious substances and disposed of in accordance with local regulations.
6. Reagents should be used within the validity period marked on the outer package. The detection card should be used as soon as possible after it is taken out of the aluminum foil bag to prevent moisture.

Logo interpretation

 


 

Do not re-use

 

Store at 2℃~30℃

Consult instructions for use

In vitro diagnostic medical

device

Batch code

Use-by date
Keep dry

Keep away from sunlight

Authorized representative in the

European Community

Manufacturer

 

Basic Information


ZHONGXIU SCIENCE AND TECHNOLOGY CO.,LTD

Dingluan industrial zone ,Changyuan City,453400,P.R.CHINA

Tel:+86-371-55016575

Email:zosbio@zosbio.com

Web:www.zosbio.com

SUNGO Europe B.V.

Olympisch Stadion 24, 1076DE Amsterdam, Netherlands

 

Company profile


 
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

 

Company Details

Bronze Gleitlager

,

Bronze Sleeve Bushings

 and 

Graphite Plugged Bushings

 from Quality China Factory
  • Business Type:

    Manufacturer,Exporter,Seller

  • Year Established:

    2016

  • Employee Number:

    500~1000

  • Ecer Certification:

    Active Member

Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is located in Dingluan Industrial Zone, Changyuan City, Henan Province. The company covers an area of about 100 acres and the initial investment is about 200 million yuan. The company has a scientific and complete management system, a purifi... Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is located in Dingluan Industrial Zone, Changyuan City, Henan Province. The company covers an area of about 100 acres and the initial investment is about 200 million yuan. The company has a scientific and complete management system, a purifi...

+ Read More

Get in touch with us

  • Reach Us
  • Henan Lantian Medical Supplies Co.,Ltd.
  • Office Address: Building 4, No. 51 Jingbei 3rd Road, Jingkai Zone, Zhengzhou City. Henan Province,China.
  • https://www.agrapidtestkit.com/

Leave a Message, we will call you back quickly!

Email

Check your email

Phone Number

Check your phone number

Requirement Details

Your message must be between 20-3,000 characters!

Submit Requirement